Aug 2, 11:49 AM

Gland Pharma's Hyderabad Facility Receives Three FDA Observations in Form 483

Gland Pharma's Hyderabad-based Pashamylaram facility has received three observations from the U.S. Food and Drug Administration (FDA) following a recent inspection. The FDA issued Form 483, detailing the observations, as confirmed by multiple sources including an exchange filing.

#Gland Pharma #Hyderabad #Pashamylaram #FDA

Written with ChatGPT (GPT-4o).

Sources

CNBC-TV18@CNBCTV18Live
2 years ago
US FDA issues Form 483 with 3 observations for Gland Pharma's Hyderabad facility https://t.co/D4ptTj1xh1
Markets Today@marketsday
2 years ago
U.S. #FDA inspection at #GlandPharma's #Hyderabad facility closes with 3 observations: Exchange filing
CNBC-TV18@CNBCTV18Live
2 years ago
#JustIn | Gland Pharma: US FDA issues form 483 with 3 observations for co’s Hyderabad-based Pashamylaram facility Here's more👇 https://t.co/i2X5S1dl2k

Gland Pharma's Hyderabad Facility Receives Three FDA Observations in Form 483

Sources

Additional media